Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Margaret P Kasaro

Biographic Data

ID5991168
NAMEMargaret P Kasaro
GIVEN NAMESMargaret P
FAMILY NAMEKasaro
SIGNATUREKASARO M P
AFFILIATIONSUniversity of North Carolina at Chapel Hill
ORCID0000-0001-7285-998X
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS1
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2026
H-INDEX1
  • Multi-Omics for Mothers and Infants (Momi) Consortium

    Open Access•Xin Tang, Salahuddin Ahmed et al.•ARTICLE•Journal of Global Health•2026

    Background: The Multi-Omics for Mothers and Infants (MOMI) Consortium aims to define biological mechanisms associated with preterm birth, small for gestational age, preeclampsia, and stillbirth. Globally, the burden of adverse pregnancy outcomes (APOs) is highest in low- and middle-income countries (LMICs). The MOMI Consortium consists of six different LMIC sites established by The Alliance for Maternal and Newborn Health Improvement in Banglades…

  • How maternal morbidities impact women’s quality of life during pregnancy and postpartum in sub-Saharan Africa and South Asia

    Open Access•Martha Ali Abdulai, Priyanka Adhikary et al.•ARTICLE•PLOS Global Public Health•2025

    Maternal morbidities present a major burden to the health and well-being of childbearing women. However, their impacts on women’s functional health are not well understood. This work aims to describe how maternal morbidities affect women’s quality of life (QoL) in pregnancy and the postpartum period . This qualitative study involved 118 pregnant and 135 postpartum women at six study sites in Kenya, Ghana, Zambia, Pakistan, and India. Data were co…

  • Mid-Trimester Allostatic Load and Spontaneous Preterm Birth in a Cohort of Pregnant Women Living with HIV in Zambia

    Open Access•Katelyn Rittenhouse, Bellington Vwalika et al.•ARTICLE•Maternal and Child Health Journal•2025

  • Engaging Family Members to Support Exclusive Breastfeeding, Responsive care, and Antiretroviral Therapy Adherence Among Families with Children who are HIV-Exposed and Uninfected

    Open Access•T F L Matenga, Harsh Agarwal et al.•ARTICLE•AIDS and Behavior•2024

    Children who are HIV-exposed and uninfected (CHEU) are at increased risk for poor growth, health, and development compared to children who are HIV-unexposed and uninfected. To support families with CHEU, we assessed the acceptability of engaging family members to support women living with HIV (WLWH) with exclusive breastfeeding (EBF) and antiretroviral therapy (ART) adherence and to engage in responsive infant caregiving. We conducted trials of i…

  • Acceptability of a Randomized Trial of Anti-depressant Medication or Interpersonal Therapy for Treatment of Perinatal Depression in Women with HIV

    Open Access•M Bridget Spelke, Eunice Okumu et al.•ARTICLE•AIDS and Behavior•2024

    Postpartum depression (PPD) affects nearly 20% of postpartum women in Sub-Saharan Africa (SSA), where HIV prevalence is high. Depression is associated with worse HIV outcomes in non-pregnant adults and mental health disorders may worsen HIV outcomes for postpartum women and their infants. PPD is effectively treated with psychosocial or pharmacologic interventions; however, few studies have evaluated the acceptability of treatment modalities in SS…

  • Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia

    Open Access•Alice F Cartwright, Rebecca L Callahan et al.•ARTICLE•Studies in Family Planning•2023•Cited by: 1•References: 29

    Few longitudinal studies have measured contraceptive continuation past one year in sub‐Saharan Africa. We surveyed 674 women who had been randomized to receive the three‐month intramuscular contraceptive injectable (DMPA‐IM), levonorgestrel (LNG) implant, or copper intrauterine device (IUD) during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial in South Africa and Zambia and were subsequently followed for two additional years…

  • ART initiation among women newly diagnosed with HIV in a contraceptive trial in sub-Saharan Africa

    Open Access•Ivana Beesham, Rodal Issema et al.•ARTICLE•AIDS Care•2022

    Current guidelines recommend starting antiretroviral therapy (ART) as soon as possible after HIV diagnosis to reduce morbidity, mortality and onward HIV transmission. We examined factors influencing ART initiation by women who seroconverted during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial. ECHO, conducted between 2015 and 2018, enrolled HIV-negative, sexually active women, aged 16-35 years, from four African countries. …

  • Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia

    Open Access•Alice F Cartwright, Rebecca L Callahan et al.•ARTICLE•Studies in Family Planning•2023•Cited by: 1•References: 29

    Few longitudinal studies have measured contraceptive continuation past one year in sub‐Saharan Africa. We surveyed 674 women who had been randomized to receive the three‐month intramuscular contraceptive injectable (DMPA‐IM), levonorgestrel (LNG) implant, or copper intrauterine device (IUD) during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial in South Africa and Zambia and were subsequently followed for two additional years…

  • ART initiation among women newly diagnosed with HIV in a contraceptive trial in sub-Saharan Africa

    Open Access•Ivana Beesham, Rodal Issema et al.•ARTICLE•AIDS Care•2022

    Current guidelines recommend starting antiretroviral therapy (ART) as soon as possible after HIV diagnosis to reduce morbidity, mortality and onward HIV transmission. We examined factors influencing ART initiation by women who seroconverted during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial. ECHO, conducted between 2015 and 2018, enrolled HIV-negative, sexually active women, aged 16-35 years, from four African countries. …

  • Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia

    Open Access•Alice F Cartwright, Rebecca L Callahan et al.•ARTICLE•Studies in Family Planning•2023•Cited by: 1•References: 29

    Few longitudinal studies have measured contraceptive continuation past one year in sub‐Saharan Africa. We surveyed 674 women who had been randomized to receive the three‐month intramuscular contraceptive injectable (DMPA‐IM), levonorgestrel (LNG) implant, or copper intrauterine device (IUD) during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial in South Africa and Zambia and were subsequently followed for two additional years…

  • Engaging Family Members to Support Exclusive Breastfeeding, Responsive care, and Antiretroviral Therapy Adherence Among Families with Children who are HIV-Exposed and Uninfected

    Open Access•T F L Matenga, Harsh Agarwal et al.•ARTICLE•AIDS and Behavior•2024

    Children who are HIV-exposed and uninfected (CHEU) are at increased risk for poor growth, health, and development compared to children who are HIV-unexposed and uninfected. To support families with CHEU, we assessed the acceptability of engaging family members to support women living with HIV (WLWH) with exclusive breastfeeding (EBF) and antiretroviral therapy (ART) adherence and to engage in responsive infant caregiving. We conducted trials of i…

  • Acceptability of a Randomized Trial of Anti-depressant Medication or Interpersonal Therapy for Treatment of Perinatal Depression in Women with HIV

    Open Access•M Bridget Spelke, Eunice Okumu et al.•ARTICLE•AIDS and Behavior•2024

    Postpartum depression (PPD) affects nearly 20% of postpartum women in Sub-Saharan Africa (SSA), where HIV prevalence is high. Depression is associated with worse HIV outcomes in non-pregnant adults and mental health disorders may worsen HIV outcomes for postpartum women and their infants. PPD is effectively treated with psychosocial or pharmacologic interventions; however, few studies have evaluated the acceptability of treatment modalities in SS…

  • How maternal morbidities impact women’s quality of life during pregnancy and postpartum in sub-Saharan Africa and South Asia

    Open Access•Martha Ali Abdulai, Priyanka Adhikary et al.•ARTICLE•PLOS Global Public Health•2025

    Maternal morbidities present a major burden to the health and well-being of childbearing women. However, their impacts on women’s functional health are not well understood. This work aims to describe how maternal morbidities affect women’s quality of life (QoL) in pregnancy and the postpartum period . This qualitative study involved 118 pregnant and 135 postpartum women at six study sites in Kenya, Ghana, Zambia, Pakistan, and India. Data were co…

  • Mid-Trimester Allostatic Load and Spontaneous Preterm Birth in a Cohort of Pregnant Women Living with HIV in Zambia

    Open Access•Katelyn Rittenhouse, Bellington Vwalika et al.•ARTICLE•Maternal and Child Health Journal•2025

  • Multi-Omics for Mothers and Infants (Momi) Consortium

    Open Access•Xin Tang, Salahuddin Ahmed et al.•ARTICLE•Journal of Global Health•2026

    Background: The Multi-Omics for Mothers and Infants (MOMI) Consortium aims to define biological mechanisms associated with preterm birth, small for gestational age, preeclampsia, and stillbirth. Globally, the burden of adverse pregnancy outcomes (APOs) is highest in low- and middle-income countries (LMICs). The MOMI Consortium consists of six different LMIC sites established by The Alliance for Maternal and Newborn Health Improvement in Banglades…

Medicine (4 works) · Family medicine (3 works) · Pregnancy (3 works) · Psychology (3 works) · Public health (3 works) · Adolescent Sexual and Reproductive Health (2 works) · Antiretroviral therapy (2 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Health psychology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae